Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment 
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal 
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant 
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 
Bank of America's $72.5M Epstein Settlement: What You Need to Know 
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth 
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 
SAN JOSE, Calif., Dec. 28, 2016 -- Vocera Communications, Inc. (NYSE:VCRA), the leading healthcare communications company, today announced that company executives will present to institutional investors at the 35th Annual JP Morgan Healthcare Conference on Thursday, Jan. 12, at 8:30 a.m. PT in San Francisco. The discussion will be available as a webcast, both live and archived, through the Vocera website at investors.vocera.com. The replay will be available for 90 days following the live broadcast.
Important Notice Regarding Forward-Looking Statements
Comments or responses to questions at the conference may contain forward-looking information, including statements regarding projected operating results and anticipated market opportunities for Vocera. This forward-looking information is subject to risks and uncertainties described in Vocera's filings with the Securities and Exchange Commission, and actual results or events may differ materially.
About Vocera
Vocera Communications, Inc. offers the most robust clinical communications system in healthcare. Vocera delivers secure, integrated and intelligent communication solutions that enable care teams to collaborate more efficiently by delivering the right information, to the right person, on the right device, in the right location, at the right time. Vocera solutions provide hands-free voice communication, secure text messaging, patient engagement tools, and integrated clinical workflow with EHRs, nurse call systems and physiologic monitors. These solutions help improve operational efficiency, quality of care, safety and satisfaction across the continuum of care. In addition to technology solutions, Vocera drives thought leadership and new standards in care to elevate patient, family, nurse and physician experiences via the company's research collaborative, the Experience Innovation Network. Vocera is led by President and CEO Brent Lang and is headquartered in San Jose, California, with offices in San Francisco, Tennessee, Indiana, Canada, India, United Arab Emirates and the United Kingdom. Robert J. Zollars is the Chairman of the Board. For more information, visit www.vocera.com and @VoceraComm on Twitter.
The Vocera logo is a trademark of Vocera Communications, Inc. Vocera® is a trademark of Vocera Communications, Inc. registered in the United States and other jurisdictions. All other trademarks appearing in this release are the property of their respective owners.
CONTACTS: Investors and Analysts: Sue Dooley Vocera 408.882.5971 [email protected] Media: Tara Stultz Amendola Communications 440.225.9595 [email protected]
